左心室整体纵向应变对脓毒症/脓毒性休克患者预后的影响:一项Meta分析
该Meta分析系统评价了二维斑点追踪成像技术(2D-STI)测定的左心室整体纵向应变(GLS)和左心室射血分数(LVEF)对脓毒症/脓毒性休克患者预后的影响。共纳入6篇文献(5篇英文、1篇中文),503例患者,存活组333例、死亡组170例,文献质量较高(NOS评分8-9分)。Meta分析显示,短期死亡率与较高的GLS相关(SMD=-0.47,95%CI=-0.76至-0.18,Z=3.16,P=0.002),而存活组与死亡组间LVEF无显著差异(SMD=0.18,95%CI=-0.03至0.39,Z=1.64,P=0.10)。敏感性分析显示结果稳定,但纳入研究数量过少,不能完全排除发表偏倚。作者认为,与LVEF相比,GLS可能是检测脓毒症/脓毒性休克患者心肌功能障碍更敏感的指标,并可能对短期死亡率有重要预测价值。
要点
- 在脓毒症/脓毒性休克患者中,短期死亡率与较高的GLS相关(SMD=-0.47,95%CI=-0.76至-0.18,P=0.002)。
- 存活组与死亡组间LVEF无显著差异(SMD=0.18,95%CI=-0.03至0.39,P=0.10)。
- 共纳入6篇文献、503例患者,存活组333例、死亡组170例,NOS评分8-9分。
- 敏感性分析显示各效应指标逐一剔除文献后合并效应无显著变化,结果稳定。
- 作者认为GLS可能较LVEF更敏感地检测脓毒症/脓毒性休克患者的心肌功能障碍,并可能对短期死亡率有重要预测价值。
适用人群与场景
- 脓毒症/脓毒性休克患者,共503例,存活组333例、死亡组170例。
研究设计与关键结果
- 研究类型为Meta分析,纳入6篇文献(5篇英文、1篇中文),共503例患者,存活组333例、死亡组170例,文献质量较高(NOS评分8-9分)。
- 短期死亡率与较高的GLS相关(SMD=-0.47,95%CI=-0.76至-0.18,Z=3.16,P=0.002)。
- 存活组与死亡组间LVEF无显著差异(SMD=0.18,95%CI=-0.03至0.39,Z=1.64,P=0.10)。
- 敏感性分析逐一剔除文献后合并效应无显著变化,结果稳定。
- 漏斗图显示各文献效应点大致呈以合并效应为中心的倒漏斗形对称分布,但纳入研究数量过少,不能完全排除发表偏倚。
证据类型、等级与局限
- 证据类型:Meta分析。
- 纳入文献质量较高,NOS评分8-9分。
- 局限性:纳入研究数量过少,不能完全排除发表偏倚。
对床旁实践的改变
- 作者认为,与LVEF相比,GLS可能是检测脓毒症/脓毒性休克患者心肌功能障碍更敏感的指标,并可能对短期死亡率有重要预测价值。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To systematically evaluate the effects of left ventricular global longitudinal strain (GLS) determined by two dimensional speckle tracking imaging technology (2D-STI) and left ventricular ejection fraction (LVEF) on the prognosis of patients with sepsis/septic shock.
METHODS: Databases such as the National Library of Medicine PubMed database, Dutch medical abstracts Embase, Cochrane Library, Netherlands Elsevier, Springer and China biomedical literature database (CBMdisc), China National Knowledge Internet (CNKI), Wanfang database, China science and technology journal full-text database, Vip Chinese biomedical journal database were searched from the establishment of literature database to April 2018 to study GLS, LVEF and their relationships with mortality of septic/septic shock patients. The literatures screening and data collecting were independently conducted by two researchers, and the quality of the included literature was evaluated. The sensitivity and heterogeneity analysis were performed with RevMan 5.3 software, and the combined effects were calculated. Funnel plot was used to evaluate publication bias.
RESULTS: A total of 6 articles including 5 English articles and 1 Chinese article were enrolled. There were 503 patients, 333 in the survival group and 170 in the death group. The quality of the literature was high, and the Newcastle-Ottawa scale (NOS) score was 8-9. Meta-analysis showed that short-term mortality was associated with higher GLS in patients with sepsis/septic shock [standardized mean difference (SMD) = -0.47, 95% confidence interval (95%CI) = -0.76 to -0.18, Z = 3.16, P = 0.002], and there was no significant difference in LVEF between the survival group and the death group (SMD = 0.18, 95%CI = -0.03-0.39, Z = 1.64, P = 0.10). Sensitivity analysis was carried out for each effect index by removing each document one by one, and the results showed that there was no significant change in the combined effect before and after each document, indicating that the results were stable. The funnel plot showed that the effect points of each literature were roughly in the form of "inverted funnels" with a large symmetric distribution centered on the combined effect, but the number of studies included in this study was too small, so the publication bias could not be completely excluded.
CONCLUSIONS: Compared with LVEF, GLS might be a more sensitive indicator for detecting myocardial dysfunction in patients with sepsis/septic shock and might have important predictive value for short-term mortality.
参考来源
- Yuan J, Chen M, Chen S, et al. [Effect of left ventricular global longitudinal strain on prognosis of septic/septic shock patients: a Meta analysis]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2018. PMID: 30309409. doi:10.3760/cma.j.issn.2095-4352.2018.09.005
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。